Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme Meintjes

Showing results (11-20 of 382) with videos related to

Pageof 39
Sort By:
The Lancet. HIV|February 15, 2026
ART timing in people being investigated for tuberculosisGraeme Meintjes, Gary Maartens
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 27, 2011
Cryptococcal meningitis--a neglected killerJoseph Jarvis, Graeme Meintjes
The Lancet. Infectious Diseases|April 15, 2014
Dosing of raltegravir when given with rifampicinGraeme Meintjes, Gary Maartens
The Lancet. Global Health|December 15, 2022
Development of accurate non-sputum-based diagnostic tests for tuberculosis: an ongoing challengeBianca Sossen, Graeme Meintjes
The Lancet. HIV|May 13, 2017
Resistance matters in EARNESTGary Maartens, Graeme Meintjes
The New England Journal of Medicine|June 4, 2010
Timing of antiretroviral drugs during tuberculosis therapyDouglas Wilson, Graeme Meintjes
The Lancet. Infectious Diseases|April 17, 2015
Lower-dose efavirenz: what is needed before implementation?Gary Maartens, Graeme Meintjes
Cold Spring Harbor Perspectives in Medicine|May 18, 2026
HIV-Associated Tuberculosis in Adults: Diagnosis and Clinical ManagementGraeme Meintjes, Bianca Sossen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2010
Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapyGraeme Meintjes, Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2009
Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programsMary-Ann Davies, Graeme Meintjes
Pageof 39

Showing results (11-20 of 382) with videos related to

Sort By:
Pageof 39
The Lancet. HIV|February 15, 2026
ART timing in people being investigated for tuberculosisGraeme Meintjes, Gary Maartens
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 27, 2011
Cryptococcal meningitis--a neglected killerJoseph Jarvis, Graeme Meintjes
The Lancet. Infectious Diseases|April 15, 2014
Dosing of raltegravir when given with rifampicinGraeme Meintjes, Gary Maartens
The Lancet. Global Health|December 15, 2022
Development of accurate non-sputum-based diagnostic tests for tuberculosis: an ongoing challengeBianca Sossen, Graeme Meintjes
The Lancet. HIV|May 13, 2017
Resistance matters in EARNESTGary Maartens, Graeme Meintjes
The New England Journal of Medicine|June 4, 2010
Timing of antiretroviral drugs during tuberculosis therapyDouglas Wilson, Graeme Meintjes
The Lancet. Infectious Diseases|April 17, 2015
Lower-dose efavirenz: what is needed before implementation?Gary Maartens, Graeme Meintjes
Cold Spring Harbor Perspectives in Medicine|May 18, 2026
HIV-Associated Tuberculosis in Adults: Diagnosis and Clinical ManagementGraeme Meintjes, Bianca Sossen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2010
Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapyGraeme Meintjes, Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2009
Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programsMary-Ann Davies, Graeme Meintjes
Pageof 39